The global organ preservation market size is expected to reach USD 410.24 million by 2030, according to a new study. The report “Organ Preservation Market Share, Size, Trends, Industry Analysis Report, By Solution; By Technique; By End-User (Organ Transplant Centers, Hospitals, Specialty Clinics); By Organ Type (Kidney, Liver, Lung, Heart, Pancreas); By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rising geriatric population and the increase in chronic diseases such as heart attacks and diabetes drive organ preservation industry growth during the forecast period. Diseases such as tuberculosis and liver cirrhosis are more prevalent in the elderly and may necessitate organ transplantation. Kidney-related ailments impact around one in three individuals with diabetes and one in five individuals suffering from high blood pressure.
Furthermore, the rising number of organ transplants in geriatric people is driving the market growth during the forecast period. According to the Organ Procurement and Transplantation Network, the increasing geriatric population significantly impacts the number of organ transplantation procedures performed, as the number of older people receiving organ transplants has increased.
For example, in the U.S., organ transplants in the over-65 age group increased from 8,691 in 2019 to 8,895 in 2021. According to the U.N. World Population, there have been 728 million people aged 65 or older in 2020; this figure is expected to rise to 1.5 billion by 2050, providing the potential for market growth. As a result, given the high vulnerability to conditions that cause organ failure, expansion in this population segment will be a significant driver of market growth.
U.W. solution segment garnered the largest revenue share. This solution can flush and store the kidneys, liver, and pancreas. It was the first cellular restoration medium widely regarded as the gold standard in organ conservation and protection. The increased adoption of U.W. solutions is attributed to the prevalence of metabolically inert substrates, which allow for better implantation outcomes, less histopathologic damage, and enhanced physiological function of organ systems when compared to other solutions.
Market players such as Avionord, Bridge to Life Limited, Carnamedica, Shanghai Genext, Dr. Franz Kohler, Transplant Biomedicals, Preservation Solutions, Essential Pharmaceuticals, Global Transplant Solutions, Institut Georges Lopez, Organ Preservation, OrganOx Limited, and Vascular Perfusion Solutions are some key players operating in the global market.
Rising geriatric population and the increase in chronic diseases such as heart attacks and diabetes drive organ preservation industry growth during the forecast period. Diseases such as tuberculosis and liver cirrhosis are more prevalent in the elderly and may necessitate organ transplantation. Kidney-related ailments impact around one in three individuals with diabetes and one in five individuals suffering from high blood pressure.
Furthermore, the rising number of organ transplants in geriatric people is driving the market growth during the forecast period. According to the Organ Procurement and Transplantation Network, the increasing geriatric population significantly impacts the number of organ transplantation procedures performed, as the number of older people receiving organ transplants has increased.
For example, in the U.S., organ transplants in the over-65 age group increased from 8,691 in 2019 to 8,895 in 2021. According to the U.N. World Population, there have been 728 million people aged 65 or older in 2020; this figure is expected to rise to 1.5 billion by 2050, providing the potential for market growth. As a result, given the high vulnerability to conditions that cause organ failure, expansion in this population segment will be a significant driver of market growth.
U.W. solution segment garnered the largest revenue share. This solution can flush and store the kidneys, liver, and pancreas. It was the first cellular restoration medium widely regarded as the gold standard in organ conservation and protection. The increased adoption of U.W. solutions is attributed to the prevalence of metabolically inert substrates, which allow for better implantation outcomes, less histopathologic damage, and enhanced physiological function of organ systems when compared to other solutions.
Market players such as Avionord, Bridge to Life Limited, Carnamedica, Shanghai Genext, Dr. Franz Kohler, Transplant Biomedicals, Preservation Solutions, Essential Pharmaceuticals, Global Transplant Solutions, Institut Georges Lopez, Organ Preservation, OrganOx Limited, and Vascular Perfusion Solutions are some key players operating in the global market.
The publisher has segmented the organ preservation market report based on solution, technique, end-use, organ type, and region:
Organ Preservation, Solution Outlook
- University of Wisconsin Solution (UW Solution)
- Custodial HTK
- Perfadex
- Other Solutions
Organ Preservation, Technique Outlook
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
Organ Preservation, End-User Outlook
- Organ Transplant Centers
- Hospitals
- Specialty Clinics
Organ Preservation, Organ Type Outlook
- Kidney
- Liver
- Lung
- Heart
- Pancreas
Organ Preservation, Regional Outlook
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Russia
- Spain
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Frequently Asked Questions about the Global Organ Preservation Market
What is the estimated value of the Global Organ Preservation Market?
What is the growth rate of the Global Organ Preservation Market?
What is the forecasted size of the Global Organ Preservation Market?
Who are the key companies in the Global Organ Preservation Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 112 |
| Published | May 2022 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 230.89 million |
| Forecasted Market Value ( USD | $ 410.24 million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Global Organ Preservation Market Insights
5. Global Organ Preservation Market, by Solution
6. Global Organ Preservation Market, by Technique
7. Global Organ Preservation Market, by End-User
8. Global Organ Preservation Market, by Organ Type
9. Global Organ Preservation Market, by Geography
10. Competitive Landscape
11. Company Profiles
Companies Mentioned
- Avionord
- Bridge to Life Limited
- Carnamedica
- Dr. Franz Kohler
- Essential Pharmaceuticals
- Global Transplant Solutions
- Institut Georges Lopez
- Organ Preservation
- OrganOx Limited
- Preservation Solutions
- Shanghai Genext
- Transplant Biomedicals
- Vascular Perfusion Solutions.
